However, unlike traditional inhibitors, telomere-targeted compounds like 6-thio-dG offer dual functionality by both disrupting GSTP1 activity and inducing telomere dysfunction (Mender et al. 2015a, b), which can further weaken cancer cell viability. Here, GSTP1 is linked to cancer.